title: Should patients stop taking aspirin for primary prevention?
authors.affiliation: Brigham and Women's Hospital Heart and Vascular Center; Harvard Medical School, Boston, MA, USA.
authors.forename: Jeremiah P
authors.initials: JP
authors.lastname: Depta
authors.affiliation: Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital Heart and Vascular Center.|Professor of Medicine, Harvard Medical School, Boston, MA, USA. E-mail: dlbhattmd@post.harvard.edu.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
mesh_terms: D001241:Aspirin / Q000009:adverse effects* / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003657:Decision Making; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin